For example, FGFR1 activation contributes to the epithelial–mesenchymal transition (EMT) and metastasis in breast cancer (44), as well as the carcinogenesis and EMT of prostate cancer (45). This evidence concerns the gene FGFR1 and prostate carcinoma.